Blood in the urine can be alarming, particularly when it occurs without pain or other symptoms. Understanding how bladder tumour is diagnosed can make the assessment process clearer: diagnosis usually involves a combination of urine testing, direct inspection of the bladder with a cystoscope, imaging of the urinary tract, and tissue analysis where needed.
A bladder tumour is an abnormal growth arising from the lining of the bladder. Not every episode of blood in the urine is caused by a tumour. Infection, stones, an enlarged prostate and some kidney conditions can also be responsible. However, visible blood in the urine should be assessed promptly, even if it has happened only once and has settled.
When assessment for a bladder tumour is needed
The most common presenting sign is haematuria, the medical term for blood in the urine. It may be visible, turning urine pink, red or brown, or found only on a urine test. Blood may come and go, so the absence of bleeding on a later day does not rule out a problem.
Some patients have urinary symptoms such as a persistent need to pass urine, burning or discomfort when passing urine, increased frequency, or recurrent urinary tract infections. These symptoms are common and often have non-cancerous causes, but they need careful assessment when they persist or occur with haematuria.
Risk is higher with increasing age and a history of smoking. Occupational exposure to certain industrial chemicals and previous pelvic radiotherapy may also be relevant. Risk factors help guide clinical judgement, but a person can develop a bladder tumour without any recognised risk factor.
Initial assessment and urine tests
Assessment begins with a medical history and examination. A urologist will ask about visible or microscopic blood in the urine, urinary symptoms, past infections or stones, medications including blood-thinning medicines, smoking history, previous cancer treatment, and family history where relevant.
A urine sample is usually tested for blood, infection and other abnormalities. If an infection is identified, it may be treated first, followed by repeat testing to confirm that the blood has resolved. Infection and a bladder tumour can occasionally occur together, so persistent haematuria still requires investigation.
Urine cytology
Urine cytology examines urine under a microscope for abnormal cells shed from the urinary tract lining. It can be particularly helpful for detecting high-grade cancer, where cells tend to look more abnormal. A normal cytology result does not exclude a bladder tumour, especially a small or low-grade tumour, so it is used alongside cystoscopy and imaging rather than as a standalone test.
Other urine-based marker tests may be considered in selected circumstances. Their role depends on the clinical setting and local practice. They do not replace direct examination of the bladder where there is a significant concern.
Cystoscopy: looking directly inside the bladder
Cystoscopy is the key test used to inspect the lining of the bladder and urethra. A slender flexible telescope with a camera is passed through the urethra into the bladder. It is commonly performed in rooms using local anaesthetic gel, although the setting can vary according to the patient and the procedure required.
The urologist can view the urethra, prostate region in men, and the bladder lining. The bladder is assessed for growths, areas of inflammation, stones and other changes. Most flexible cystoscopies take only a short time. Patients may experience temporary burning when passing urine or a small amount of blood afterwards. Drinking extra water for the rest of the day may help, unless fluid intake has been restricted for another medical reason.
Cystoscopy is highly useful because many bladder tumours are visible. However, a lesion may need removal or biopsy before its nature can be confirmed. Flat, high-grade changes in the bladder lining can also be subtle, which is one reason urine cytology and clinical history remain relevant.
Imaging of the kidneys, ureters and bladder
Imaging checks the whole urinary tract, not just the bladder. The kidneys and ureters can also be sources of bleeding, and tumours may arise in these areas less commonly.
A CT urogram is often the preferred scan for patients with haematuria who are suitable for contrast imaging. It provides detailed images of the kidneys, ureters and bladder, and can identify masses, stones, blockage or enlarged lymph nodes. The contrast dye is usually given through a vein. Kidney function, allergy history and other health conditions are reviewed before the scan.
An ultrasound may be used in some situations, including when CT contrast is unsuitable or when a less intensive initial study is appropriate. Ultrasound is useful for assessing the kidneys and can identify some bladder abnormalities, but it does not replace cystoscopy and may not detect small bladder lesions. The choice of scan depends on age, symptoms, kidney function, previous imaging and the level of clinical concern.
Confirming the diagnosis with tumour resection and biopsy
If cystoscopy identifies a suspected bladder tumour, the next step is usually a transurethral resection of bladder tumour, often abbreviated to TURBT. This is both a treatment and a diagnostic procedure.
TURBT is performed in hospital under anaesthetic. A telescope is passed through the urethra, so there is no external incision. The surgeon removes the visible tumour and samples tissue from the underlying bladder wall. The specimen is sent to a pathologist, who examines it under a microscope.
The pathology report confirms whether cancer is present and provides details that determine further care. These include the tumour type, grade and depth of invasion. Most bladder cancers are urothelial carcinomas, arising from the cells that line the urinary tract.
Grade and stage are different
Grade describes how abnormal the cancer cells look under the microscope. Low-grade tumours usually grow more slowly and are less likely to invade. High-grade tumours have a greater risk of recurrence and progression, requiring closer surveillance and sometimes additional treatment.
Stage describes how deeply the tumour has grown. A non-muscle-invasive bladder cancer is limited to the inner lining or connective tissue beneath it. A muscle-invasive bladder cancer has grown into the bladder muscle and requires a different treatment discussion, which may involve major surgery, systemic therapy, radiotherapy, or a combination of treatments depending on the individual situation.
The first resection does not always provide the final answer. Where a tumour is high-grade, large, incompletely removed, or has reached certain layers beneath the lining, a repeat resection may be recommended. This can confirm accurate staging and ensure no residual tumour remains.
What happens after diagnosis
Further investigations are guided by the pathology result. For non-muscle-invasive tumours, treatment may include medication placed directly into the bladder after resection or as a course of intravesical treatment. Ongoing cystoscopic surveillance is central to care because bladder tumours can recur, including after successful initial removal.
For muscle-invasive disease, staging scans are used to assess whether cancer has spread beyond the bladder. Treatment planning is individualised and should consider tumour stage, overall health, kidney function, previous treatment, and the patient’s priorities. Where surgery is appropriate, a specialist urological assessment helps clarify the likely benefits, risks and recovery involved.
When to seek prompt medical advice
Visible blood in urine should not be assumed to be an infection, particularly if there is no pain or if it returns after treatment. Seek timely medical assessment for blood in the urine, recurrent urinary infections, difficulty passing urine, unexplained urinary symptoms, or blood clots in the urine. If urine cannot be passed, severe pain develops, or bleeding is heavy, urgent medical care is required.
A clear diagnosis relies on combining the right tests rather than relying on a single result. Early specialist assessment provides the best opportunity to identify the cause of haematuria, confirm a bladder tumour accurately if present, and plan treatment with confidence.
Recent Comments